User menu

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.

Bibliographic reference Sommereyns, Caroline ; Paul, Sophie ; Staeheli, Peter ; Michiels, Thomas. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.. In: PLoS Pathogens, Vol. 4, no. 3, p. e1000017 (2008)
Permanent URL http://hdl.handle.net/2078.1/11334
  1. Isaacs A., Lindenmann J., Virus Interference. I. The Interferon, 10.1098/rspb.1957.0048
  2. Goodbourn S., Randall R. E., Didcock L., Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures, 10.1099/0022-1317-81-10-2341
  3. Zwarthoff Ellen C., Mooren Arno T A., Trapman Jan, Organization, structure and expression of murine interferon alpha genes, 10.1093/nar/13.3.791
  4. Pestka Sidney, Krause Christopher D., Walter Mark R., Interferons, interferon-like cytokines, and their receptors, 10.1111/j.0105-2896.2004.00204.x
  5. van Pesch V., Lanaya H., Renauld J.-C., Michiels T., Characterization of the Murine Alpha Interferon Gene Family, 10.1128/jvi.78.15.8219-8228.2004
  6. LaFleur David W., Nardelli Bernardetta, Tsareva Tatiana, Mather Don, Feng Ping, Semenuk Mark, Taylor Kara, Buergin Markus, Chinchilla Diana, Roshke Viktor, Chen Guoxian, Ruben Steven M., Pitha Paula M., Coleman Timothy A., Moore Paul A., Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes, 10.1074/jbc.m102502200
  7. Hardy Matthew P., Owczarek Catherine M., Jermiin Lars S., Ejdebäck Mikael, Hertzog Paul J., Characterization of the type I interferon locus and identification of novel genes☆, 10.1016/j.ygeno.2004.03.003
  8. Oritani Kenji, Kincade Paul W, Zhang Cai, Tomiyama Yoshiaki, Matsuzawa Yuji, Type I interferons and limitin: a comparison of structures, receptors, and functions, 10.1016/s1359-6101(01)00009-0
  9. Sommereyns Caroline, Michiels Thomas, N-Glycosylation of Murine IFN-βin a Putative Receptor-Binding Region, 10.1089/jir.2006.26.406
  10. van Pesch Vincent, Michiels Thomas, Characterization of Interferon-α 13, a Novel Constitutive Murine Interferon-α Subtype, 10.1074/jbc.m302554200
  11. Huang J., Smirnov S. V., Lewis-Antes A., Balan M., Li W., Tang S., Silke G. V., Putz M. M., Smith G. L., Kotenko S. V., Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus, 10.1073/pnas.0610352104
  12. Jaitin D. A., Roisman L. C., Jaks E., Gavutis M., Piehler J., Van der Heyden J., Uze G., Schreiber G., Inquiring into the Differential Action of Interferons (IFNs): an IFN- 2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN- , 10.1128/mcb.26.5.1888-1897.2006
  13. Jaks Eva, Gavutis Martynas, Uzé Gilles, Martal Jacques, Piehler Jacob, Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation, 10.1016/j.jmb.2006.11.053
  14. Kotenko Sergei V., Gallagher Grant, Baurin Vitaliy V., Lewis-Antes Anita, Shen Meiling, Shah Nital K., Langer Jerome A., Sheikh Faruk, Dickensheets Harold, Donnelly Raymond P., IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex, 10.1038/ni875
  15. Sheppard Paul, Kindsvogel Wayne, Xu Wenfeng, Henderson Katherine, Schlutsmeyer Stacy, Whitmore Theodore E., Kuestner Rolf, Garrigues Ursula, Birks Carl, Roraback Jenny, Ostrander Craig, Dong Dennis, Shin Jinu, Presnell Scott, Fox Brian, Haldeman Betty, Cooper Emily, Taft David, Gilbert Teresa, Grant Francis J., Tackett Monica, Krivan William, McKnight Gary, Clegg Chris, Foster Don, Klucher Kevin M., IL-28, IL-29 and their class II cytokine receptor IL-28R, 10.1038/ni873
  16. Lasfar Ahmed, Lewis-Antes Anita, Smirnov Sergey V., Anantha Shubha, Abushahba Walid, Tian Bin, Reuhl Kenneth, Dickensheets Harold, Sheikh Faruk, Donnelly Raymond P., Raveche Elizabeth, Kotenko Sergei V., Characterization of the Mouse IFN-λ Ligand-Receptor System: IFN-λs Exhibit Antitumor Activity against B16 Melanoma, 10.1158/0008-5472.can-05-3653
  17. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A. R., Paludan S. R., Lambda Interferon (IFN- ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo, 10.1128/jvi.80.9.4501-4509.2006
  18. Uzé Gilles, Monneron Danièle, IL-28 and IL-29: Newcomers to the interferon family, 10.1016/j.biochi.2007.01.008
  19. Onoguchi Kazuhide, Yoneyama Mitsutoshi, Takemura Azumi, Akira Shizuo, Taniguchi Tadatsugu, Namiki Hideo, Fujita Takashi, Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism, 10.1074/jbc.m608618200
  20. Osterlund P., Veckman V., Siren J., Klucher K. M., Hiscott J., Matikainen S., Julkunen I., Gene Expression and Antiviral Activity of Alpha/Beta Interferons and Interleukin-29 in Virus-Infected Human Myeloid Dendritic Cells, 10.1128/jvi.79.15.9608-9617.2005
  21. Yang Kun, Puel Anne, Zhang Shenying, Eidenschenk Céline, Ku Cheng-Lung, Casrouge Armanda, Picard Capucine, von Bernuth Horst, Senechal Brigitte, Plancoulaine Sabine, Al-Hajjar Sami, Al-Ghonaium Abdulaziz, Maródi László, Davidson Donald, Speert David, Roifman Chaim, Garty Ben-Zion, Ozinsky Adrian, Barrat Franck J., Coffman Robert L., Miller Richard L., Li Xiaoxia, Lebon Pierre, Rodriguez-Gallego Carlos, Chapel Helen, Geissmann Frédéric, Jouanguy Emmanuelle, Casanova Jean-Laurent, Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses, 10.1016/j.immuni.2005.09.016
  22. Domanski Paul, Witte Michael, Kellum Merril, Rubinstein Menachem, Hackett Rebecca, Pitha Paula, Colamonici Oscar R., Cloning and Expression of a Long Form of the β Subunit of the Interferon αβ Receptor That Is Required for Signaling, 10.1074/jbc.270.37.21606
  23. DUMOUTIER Laure, LEJEUNE Diane, HOR Simon, FICKENSCHER Helmut, RENAULD Jean-Christophe, Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3, 10.1042/bj20021935
  24. Brand S., IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression, 10.1152/ajpgi.00126.2005
  25. Dumoutier Laure, Tounsi Amel, Michiels Thomas, Sommereyns Caroline, Kotenko Sergei V., Renauld Jean-Christophe, Role of the Interleukin (IL)-28 Receptor Tyrosine Residues for Antiviral and Antiproliferative Activity of IL-29/Interferon-λ1 : SIMILARITIES WITH TYPE I INTERFERON SIGNALING, 10.1074/jbc.m404789200
  26. Zhou Z., Hamming O. J., Ank N., Paludan S. R., Nielsen A. L., Hartmann R., Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases, 10.1128/jvi.02438-06
  27. Platanias L, Signaling pathways activated by interferons, 10.1016/s0301-472x(99)00109-5
  28. Ank Nina, West Hans, Paludan Søren R., IFN-λ: Novel Antiviral Cytokines, 10.1089/jir.2006.26.373
  29. Bartlett N. W., Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model, 10.1099/vir.0.80904-0
  30. Sato A., Ohtsuki M., Hata M., Kobayashi E., Murakami T., Antitumor Activity of IFN-  in Murine Tumor Models, 10.4049/jimmunol.176.12.7686
  31. Jordan W J, Eskdale J, Boniotto M, Rodia M, Kellner D, Gallagher G, Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29), 10.1038/sj.gene.6364348
  32. Jordan W J, Eskdale J, Srinivas S, Pekarek V, Kelner D, Rodia M, Gallagher G, Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response, 10.1038/sj.gene.6364382
  33. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., Michiels T., Neurons produce type I interferon during viral encephalitis, 10.1073/pnas.0602460103
  34. Matthews Ae, Weiss Sr, Paterson Y, Murine hepatitis virus--A model for virus-induced CNS demyelination, 10.1080/13550280290049534
  35. Plagemann Peter G.W., Moennig Volker, Lactate Dehydrogenase-Elevating Virus, Equine Arteritis Virus, and Simian Hemorrhagic Fever Virus: A New Group of Positive-Strand RNA Viruses, Advances in Virus Research (1992) ISBN:9780120398416 p.99-192, 10.1016/s0065-3527(08)60036-6
  36. Stueckemann J. A., Holth M., Swart W. J., Kowalchyk K., Smith M. S., Wolstenholme A. J., Cafruny W. A., Plagemann P. G. W., Replication of Lactate Dehydrogenase-elevating Virus in Macrophages: 2. Mechanism of Persistent Infection in Mice and Cell Culture, 10.1099/0022-1317-59-2-263
  37. Anderson G. W., Palmer G. A., Rowland R. R. R., Even C., Plagemann P. G. W., Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons, 10.1099/0022-1317-76-3-581
  38. H Dubuy, Infect Immun, 8, 977 (1973)
  39. Blakqori G., Delhaye S., Habjan M., Blair C. D., Sanchez-Vargas I., Olson K. E., Attarzadeh-Yazdi G., Fragkoudis R., Kohl A., Kalinke U., Weiss S., Michiels T., Staeheli P., Weber F., La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts, 10.1128/jvi.01933-06
  40. Brahic Michel, Bureau Jean-François, Michiels Thomas, THE GENETICS OF THE PERSISTENT INFECTION AND DEMYELINATING DISEASE CAUSED BY THEILER'S VIRUS, 10.1146/annurev.micro.59.030804.121242
  41. RP Roos, 427 (2002)
  42. Li S, Zhang X, Xia X, Zhou L, Breau R, Suen J, Hanna E, Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site, 10.1038/sj.gt.3301418
  43. Coccia Eliana M., Severa Martina, Giacomini Elena, Monneron Danièle, Remoli Maria Elena, Julkunen Ilkka, Cella Marina, Lande Roberto, Uzé Gilles, Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells, 10.1002/eji.200324610
  44. Jouanguy Emmanuelle, Zhang Shen-Ying, Chapgier Ariane, Sancho-Shimizu Vanessa, Puel Anne, Picard Capucine, Boisson-Dupuis Stéphanie, Abel Laurent, Casanova Jean-Laurent, Human primary immunodeficiencies of type I interferons, 10.1016/j.biochi.2007.04.016
  45. Paul Sophie, Ricour Céline, Sommereyns Caroline, Sorgeloos Frédéric, Michiels Thomas, Type I interferon response in the central nervous system, 10.1016/j.biochi.2007.02.009
  46. Adorini Luciano, Immunotherapeutic approaches in multiple sclerosis, 10.1016/j.jns.2004.04.014
  47. Neuhaus Oliver, Archelos Juan J., Hartung Hans-Peter, Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection, 10.1016/s0165-6147(03)00028-2
  48. Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R., Issazadeh-Navikas S., IFN-  Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis, 10.4049/jimmunol.170.9.4776
  49. , Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial, 10.1212/wnl.43.4.655
  50. Dieperink E., Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review, 10.1176/appi.ajp.157.6.867
  51. Raison Charles L, Demetrashvili Marina, Capuron Lucile, Miller Andrew H, Neuropsychiatric Adverse Effects of Interferon-?? : Recognition and Management, 10.2165/00023210-200519020-00002
  52. Levraud J.-P., Boudinot P., Colin I., Benmansour A., Peyrieras N., Herbomel P., Lutfalla G., Identification of the Zebrafish IFN Receptor: Implications for the Origin of the Vertebrate IFN System, 10.4049/jimmunol.178.7.4385
  53. Contoli Marco, Message Simon D, Laza-Stanca Vasile, Edwards Michael R, Wark Peter A B, Bartlett Nathan W, Kebadze Tatiana, Mallia Patrick, Stanciu Luminita A, Parker Hayley L, Slater Louise, Lewis-Antes Anita, Kon Onn M, Holgate Stephen T, Davies Donna E, Kotenko Sergei V, Papi Alberto, Johnston Sebastian L, Role of deficient type III interferon-λ production in asthma exacerbations, 10.1038/nm1462
  54. Horisberger M. A., Staeheli P., Haller O., Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus., 10.1073/pnas.80.7.1910
  55. Koerner I., Kochs G., Kalinke U., Weiss S., Staeheli P., Protective Role of Beta Interferon in Host Defense against Influenza A Virus, 10.1128/jvi.01718-06
  56. Blakqori G., Weber F., Efficient cDNA-Based Rescue of La Crosse Bunyaviruses Expressing or Lacking the Nonstructural Protein NSs, 10.1128/jvi.79.16.10420-10428.2005
  57. C Godfraind, J Virol, 69, 6541 (1995)
  58. Coutelier Jean-Paul, Van Snick Jacques, Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus, 10.1002/eji.1830150308
  59. Chomczynski Piotr, Sacchi Nicoletta, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, 10.1016/0003-2697(87)90021-2
  60. Paul S., Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness, 10.1099/vir.0.81642-0
  61. Kunkel T. A., Rapid and efficient site-specific mutagenesis without phenotypic selection., 10.1073/pnas.82.2.488
  62. G Vandermeulen, Journal of Controlled Release (2007)
  63. DeWever Julie, Frérart Françoise, Bouzin Caroline, Baudelet Christine, Ansiaux Réginald, Sonveaux Pierre, Gallez Bernard, Dessy Chantal, Feron Olivier, Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment, 10.2353/ajpath.2007.060968
  64. E Meier, J Virol, 62, 2386 (1988)